-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
2023-05-12
The Digital Journey of a Bag of Intravenous Fluids
Shijiazhuang Sihua Pharmaceutical Group is a leading enterprise in China’s large-volume parenteral solutions industry. In recent years, Shijiazhuang Sihua has comprehensively upgraded its production equipment for large-volume parenteral solutions and adopted digital technologies, significantly enhancing the company’s core competitiveness. Last December, the company’s proposed project on digital R&D and design of pharmaceutical products was included in the 2022 List of Outstanding Smart Manufacturing Scenarios released by four government departments, including the Ministry of Industry and Information Technology and the National Development and Reform Commission.
2022-12-22
A New Era, a New Journey, and Great New Achievements | Shijiazhuang Sihua Pharmaceutical Group Integrates Industry, Academia, and Research, Receiving Approval for New Products Every Month
On December 5, in the liquid-phase laboratory of the Pharmaceutical Research Institute of Shijiazhuang Sihua Pharmaceutical Group, Yang Xian, head of the group’s Innovation Department, stared intently at the instrument screen, carefully recording the purity data for ADN-9, an innovative drug for combating liver fibrosis. Team members were busily working—some handling small and large test tubes and various instruments—each person engaged in a tense yet orderly manner.
2022-11-21
Tian Pengmei, CEO of Shijiazhuang Fourth Pharmaceutical Group and General Manager of the Strategic Development and Human Resources Center: Building a bigger stage for talents to showcase their abilities.
“High-end talent can both come in and stay—key to this is providing them with a platform where they can fully demonstrate their abilities,” said Tian Pengmei, Executive President of Shijiazhuang Fourth Pharmaceutical Group and General Manager of the Strategic Development and Human Resources Center. She noted that the 20th National Congress of the Communist Party of China has charted the course for enterprises to further enhance their talent-development efforts. In the future, the group will adopt even more robust measures to create an even bigger stage for talented individuals to showcase their skills and potential.
At Shijiazhuang Sihua Pharmaceutical Co., Ltd., the “New Drug Formulation Production Line Construction Project,” with an investment of 110 million yuan, is currently undergoing equipment commissioning. Once operational, the production capacity for oral formulations will triple compared to the original level.
02
2022/11
Shijiazhuang Sihua Pharmaceutical Co., Ltd., located in the Shijiazhuang High-Tech Industrial Development Zone, has long adhered to a “green pharmaceutical” development philosophy centered on resource recycling and energy conservation and emission reduction. Guided by the technological directions of environmental friendliness, diversification, and modularity, the company implements a green innovation strategy and is committed to promoting green, circular, and low-carbon development.
20
2022/10
On September 16, the formulation production workshop of Shijiazhuang Siyao Group, located in the Shijiazhuang High-tech Zone, was bustling with a lively and busy atmosphere. Employees were working at full speed to meet production targets and fulfill orders, making every effort to achieve the third-quarter goals.
16
2022/09
Currently, with the rapid advancement of internet, information technology, and automation, the production of pharmaceutical packaging materials is undergoing an upgrade toward automation and intelligentization. Shijiazhuang Siyao Group Jiangsu Bosheng Medical New Materials Co., Ltd. (Bosheng Medical Materials; stock code: 873710), a domestic company specializing in the R&D, production, and sales of new medical packaging materials, is actively transitioning from traditional manufacturing to “intelligent manufacturing.”
03
2022/09
In recent days, while interviewing at Shijiazhuang Sihua Pharmaceutical Group and walking through each of its factory areas, the reporter felt as if he were strolling through a garden. This “garden-style” enterprise leaves every visitor with a profound “first impression.”
17
2022/08
Sweat waters the fruits, and hard work makes dreams come true. As night falls, the bright and spacious laboratories of Shijiazhuang Fourth Pharmaceutical R&D Center glow with lights. Yang Xian, head of the Innovation Department, and her colleagues are still deeply engrossed in their work, sorting through the day’s experimental analysis data. Right now, there are many, many Shijiazhuang Fourth Pharmaceutical employees—just like them—who are “racing against time.”
15
2022/08
Shijiazhuang No.4 Pharmaceutical Group actively responds to the call of the Municipal Party Committee and the Municipal Government, seizes development opportunities, and strengthens its sense of responsibility. Guided by the goal of ensuring smooth dual circulation in both domestic and international markets, the group leverages its comparative advantages, builds competitive strengths, and achieves remarkable economic and social benefits, consistently delivering impressive performance results.
12
2022/08
Shijiazhuang Sihua Group Youyi Chemical: Accelerating High-Quality Development
Stepping into Cangzhou Lingang Youyi Chemical Co., Ltd., located in the Coastal Industrial Park of the Bohai New Area in Cangzhou, one is greeted by a lush, green campus and orderly workshops—every corner exudes a thriving and vibrant atmosphere.
10
2022/08
In the height of summer, all things flourish and thrive. On the morning of July 8, Jiangsu Bosheng Medical New Materials Co., Ltd., a subsidiary of Shijiazhuang No.4 Pharmaceutical Group, experienced a double celebration: Bosheng Medical Materials (stock code: 873710) was listed on the Innovation Layer, and the groundbreaking ceremony for its new biomembrane workshop was held simultaneously.
09
2022/08
On the afternoon of July 14, Zhang Chaochao, Secretary of the Municipal Party Committee, held a working meeting with Jin Nengming, Secretary of the Party Committee of China Pharmaceutical University, and his delegation. During the meeting, the two sides exchanged views and coordinated efforts on deepening university-local cooperation, achieving win-win development, and contributing to the city’s biomedical industry in taking the lead in making breakthroughs.
18
2022/07
SERVICE HOTLINE
Mobile site
E code
Business license